GlaxoSmithKline

Pharma / Pharma and biotechnology

Founded: 2000 | Country: UK | Ticker: GSK | ISIN: GB00BN7SWP63 | Rate: 3000

Info

Overview Core Facts Blog Ratings Executives

Analytics

Company Q&A Industry Q&A Competitors Stock Swings SWOT PEST Porter's Five Forces Score Positive Risks Revenue Segmentation

Financials

Income Statement Balance Sheet Cash Flow Statement

Ratios

Financial Ratios Financial Growth Enterprise Value Key Metrics Dividends

Tools

Due Diligence

Resources

News Clusters SEC Filings Stock Split History Press Releases Insider Trades Owner Earnings Earnings Calendar Web Reports

Income Statement

Pay attention and research significant changes from year to year values. [ ! ]

Fixed Column	Revenue	Cost of Revenue	Gross Profit	R&D Expenses	General And Administrative Expenses	Selling General And Administrative Expenses	Other Expenses	Operating Expenses	Cost And Expenses	Interest Income	Interest Expense	Depreciation And Amortization	EBITDA	EBITDA Ratio	Operating Income	Operating Income Ratio	Total Other Income Expenses Net	Income Before Tax	Income Before Tax Ratio	Income Tax Expense	Net Income	Net Income Ratio	EPS	EPS Diluted	Weighted Average Shares Out	Weighted Average Shares Out Diluted
2024-12	31376.0	9048.0	22328.0	6401.0	11015.0	11015.0	891.0	18307.0	27355.0	60.0	640.0	2551.0	6668.0	0.21	4021.0	0.12	-544.0	3477.0	0.11	526.0	2575.0	0.08	0.63	0.62	4080.0	4141.0
2023-12	30328.0	8565.0	21763.0	6223.0	9385.0	9385.0	-590.0	15018.0	23583.0	40.0	775.0	2294.0	9138.0	0.3	6745.0	0.22	-681.0	6064.0	0.19	756.0	4928.0	0.16	1.22	1.2	4052.0	4111.0
2022-12	29324.0	9554.0	19770.0	5488.0	8372.0	8372.0	-523.0	13337.0	22891.0	76.0	879.0	2147.0	8629.0	0.3	6433.0	0.21	-805.0	5628.0	0.19	707.0	4921.0	0.16	1.22	1.2	4026.0	4084.0
2021-12	34114.0	11603.0	22511.0	5278.0	10975.0	10975.0	57.0	16310.0	27913.0	28.0	784.0	2122.0	7756.0	0.25	6201.0	0.18	-758.0	5442.0	0.15	346.0	4385.0	0.12	1.37	1.35	3202.4	3241.6

Discover additional income statement data for GlaxoSmithKline!

What is special about us?

Imprint

Disclaimer

×
Disclaimer

InsightfulValue is an independent platform dedicated to value investing research. The information provided on this website is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice.
We are not financial advisors, investment consultants, or licensed consultants. Our analyses, insights, and criteria are based on principles learned from renowned value investors such as Benjamin Graham, Warren Buffett, and Charlie Munger, but they should not be considered personalized investment recommendations.
Investing in financial markets carries risks, and past performance is not indicative of future results. Users of this website should conduct their own due diligence and consult with a qualified professional before making any financial or investment decisions. InsightfulValue assumes no liability for any financial losses or decisions made based on the information provided on this site.
By using this website, you acknowledge and accept that all investments involve risk and that InsightfulValue does not guarantee any financial outcomes.

Legal

Due Diligence

This feature is only available for users with Insider or Visionary license. Please, signup or login.